The stock of Teladoc Health Inc (NYSE: TDOC) has increased by 4.88 when compared to last closing price of 8.41. Despite this, the company has experienced a -0.56% fall in its stock price over the last five trading sessions. zacks.com reported 2025-03-19 that In the latest trading session, Teladoc (TDOC) closed at $8.49, marking a +1.19% move from the previous day.
Is It Worth Investing in Teladoc Health Inc (NYSE: TDOC) Right Now?
The 36-month beta value for TDOC is also noteworthy at 1.72. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 3 rating it as “overweight,” 19 rating it as “hold,” and 0 rating it as “sell.”
The public float for TDOC is 171.93M, and at present, short sellers hold a 14.55% of that float. The average trading volume of TDOC on March 25, 2025 was 7.54M shares.
TDOC’s Market Performance
TDOC stock saw a decrease of -0.56% in the past week, with a monthly decline of -23.37% and a quarterly a decrease of -6.77%. The volatility ratio for the week is 5.06%, and the volatility levels for the last 30 days are 6.20% for Teladoc Health Inc (TDOC). The simple moving average for the past 20 days is -3.34% for TDOC’s stock, with a -6.48% simple moving average for the past 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Goldman repeating the rating for TDOC by listing it as a “Buy.” The predicted price for TDOC in the upcoming period, according to Goldman is $14 based on the research report published on November 15, 2024 of the previous year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $10, previously predicting the price at $8. The rating they have provided for TDOC stocks is “Hold” according to the report published on September 17th, 2024.
Cantor Fitzgerald gave a rating of “Overweight” to TDOC, setting the target price at $22 in the report published on February 29th of the previous year.
TDOC Trading at -14.59% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.86% of loss for the given period.
Volatility was left at 6.20%, however, over the last 30 days, the volatility rate increased by 5.06%, as shares sank -22.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.82% lower at present.
During the last 5 trading sessions, TDOC fell by -0.56%, which changed the moving average for the period of 200-days by -18.86% in comparison to the 20-day moving average, which settled at $9.13. In addition, Teladoc Health Inc saw -2.97% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from Murthy Mala, who sale 20,586 shares at the price of $8.42 back on Mar 20 ’25. After this action, Murthy Mala now owns 116,309 shares of Teladoc Health Inc, valued at $173,416 using the latest closing price.
Vandervoort Adam C, the CHIEF LEGAL OFFICER, SECRETARY of Teladoc Health Inc, sale 11,011 shares at $8.42 during a trade that took place back on Mar 20 ’25, which means that Vandervoort Adam C is holding 64,308 shares at $92,757 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.09 for the present operating margin
- 0.63 for the gross margin
The net margin for Teladoc Health Inc stands at -0.39. The total capital return value is set at -0.09. Equity return is now at value -52.46, with -23.65 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 1.06. The interest coverage ratio of the stock is -9.2.
Currently, EBITDA for the company is -587.01 million with net debt to EBITDA at -0.49. When we switch over and look at the enterprise to sales, we see a ratio of 0.71. The receivables turnover for the company is 11.47for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.73.
Conclusion
In summary, Teladoc Health Inc (TDOC) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
